{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:16:03Z","timestamp":1793218563860,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejphar.2025.177520","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:29:07Z","timestamp":1742052547000},"page":"177520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Exploring Alzheimer's disease treatment: Established therapies and novel strategies for future care"],"prefix":"10.1016","volume":"998","author":[{"given":"Urvashi","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-6094","authenticated-orcid":false,"given":"Rohini","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejphar.2025.177520_bib1","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jsps.2022.10.004","article-title":"An update on the novel and approved drugs for Alzheimer disease","volume":"30","author":"Alhazmi","year":"2022","journal-title":"Saudi Pharm. J."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177520_bib2","article-title":"The role of estrogen therapy as a protective factor for Alzheimer's disease and dementia in postmenopausal women: a comprehensive review of the literature","volume":"15","author":"Ali","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00894-010-0841-2","article-title":"Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease","volume":"17","author":"Ara\u00fajo","year":"2011","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ejphar.2025.177520_bib4","first-page":"3233","article-title":"Nootropic activity of isorhamnetin in amyloid beta 25-35 induced cognitive dysfunction and its related MRNA expressions in Alzheimer's disease","volume":"7","author":"Asha","year":"2016","journal-title":"Int. J. Pharmaceut. Sci. Res."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177520_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/genes12111833","article-title":"Dyrk1a from gene function in development and physiology to dosage correction across life span in down syndrome","volume":"12","author":"Atas-Ozcan","year":"2021","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010154","article-title":"Piperine and its metabolite's pharmacology in neurodegenerative and neurological diseases","volume":"10","author":"Azam","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","article-title":"The duality of amyloid-\u03b2: its role in normal and Alzheimer's disease states","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-021-00732-z","article-title":"Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease","volume":"19","author":"Balmik","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2025.177520_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106729","article-title":"Structure and function meet at the nicotinic acetylcholine receptor-lipid interface","volume":"190","author":"Barrantes","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/acsptsci.1c00200","article-title":"In silico and ex vivo analyses of the inhibitory action of the alzheimer drug posiphen and primary metabolites with human acetyl- and butyrylcholinesterase enzymes","volume":"5","author":"Batool","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"15","key":"10.1016\/j.ejphar.2025.177520_bib11","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.3390\/ijms23158417","article-title":"BDNF therapeutic mechanisms in neuropsychiatric disorders","volume":"23","author":"Bazzari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177520_bib12","series-title":"Synbiotics in Human Health: Biology to Drug Delivery","first-page":"97","article-title":"Role of synbiotics in neurodegenerative diseases","author":"Bhatt","year":"2024"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib14","article-title":"Polyphenols: multipotent therapeutic agents in neurodegenerative diseases","volume":"2013","author":"Bhullar","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28103993","article-title":"The potential of Ginkgo biloba as a source of biologically active compounds-A review of the recent literature and patents","volume":"28","author":"Biernacka","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib16","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12877-018-0857-5","article-title":"Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients","volume":"18","author":"Blanco-Silvente","year":"2018","journal-title":"BMC Geriatr."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2174\/1567205015666180613112040","article-title":"Strategies for continued successful treatment in patients with Alzheimer's disease: an overview of switching between pharmacological agents","volume":"15","author":"Blesa","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib19","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/ad795c","article-title":"Innovative 3D bioprinting approaches for advancing brain science and medicine: a literature review","volume":"10","author":"Bocheng","year":"2024","journal-title":"Biomed. Phys. Eng. Express"},{"issue":"21","key":"10.1016\/j.ejphar.2025.177520_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16210","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model","volume":"16","author":"Bond","year":"2012","journal-title":"Health Technol. Assess."},{"issue":"13\u201314","key":"10.1016\/j.ejphar.2025.177520_bib21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","article-title":"Monoamine oxidase inactivation: from pathophysiology to therapeutics","volume":"60","author":"Bortolato","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"24","key":"10.1016\/j.ejphar.2025.177520_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer's disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"issue":"s1","key":"10.1016\/j.ejphar.2025.177520_bib23","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.3233\/JAD-240719","article-title":"The therapeutic potential of yoga for Alzheimer's disease: a critical review","volume":"101","author":"Brown","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"s1","key":"10.1016\/j.ejphar.2025.177520_bib24","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.3233\/JAD-240719","article-title":"The therapeutic potential of yoga for alzheimer's disease: a critical review","volume":"101","author":"Brown","year":"2024","journal-title":"J. Alzheim. Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JPD-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2015","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2004.03.001","article-title":"ACE2, a new regulator of the renin-angiotensin system","volume":"15","author":"Burrell","year":"2004","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073733","article-title":"Targeting N-Methyl-d-Aspartate receptors in neurodegenerative diseases","volume":"25","author":"Carles","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 4","key":"10.1016\/j.ejphar.2025.177520_bib28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/aws072","article-title":"Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury","volume":"135","author":"Casha","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib29","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s10571-023-01344-6","article-title":"The use of stem cells as a potential treatment method for selected neurodegenerative diseases: review","volume":"43","author":"Cecerska-Hery\u0107","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00595-7","article-title":"The gut microbiome in Alzheimer's disease: what we know and what remains to be explored","volume":"18","author":"Chandra","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177520_bib31","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.4103\/NRR.NRR-D-23-01927","article-title":"Potential of molecular chaperones for treating Alzheimer's disease","volume":"19","author":"Chen","year":"2024","journal-title":"Neural. Regen. Res"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061309","article-title":"Neuroprotective natural products for Alzheimer's disease","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092488","article-title":"Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities","volume":"11","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.14283\/jpad.2023.123","article-title":"Lecanemab clarity AD: quality-of-life results from a randomized, double-blind phase 3 trial in early Alzheimer's disease","volume":"10","author":"Cohen","year":"2023","journal-title":"J. Prev. Alzheimers. Dis"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11020213","article-title":"Naturally occurring antioxidant therapy in Alzheimer's disease","volume":"11","author":"Collins","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer's disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejphar.2025.177520_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fncel.2014.00362","article-title":"The impact of microglial activation on blood-brain barrier in brain diseases","volume":"8","author":"da Fonseca","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010016","article-title":"The nerve growth factor metabolic pathway dysregulation as cause of Alzheimer's cholinergic atrophy","volume":"11","author":"Do Carmo","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib43","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.freeradbiomed.2010.11.026","article-title":"Neuroprotective strategies involving ROS in Alzheimer disease","volume":"51","author":"Dumont","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0043-1774738","article-title":"Yoga as adjunct therapy for chronic heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Dutta","year":"2023","journal-title":"Avicenna. J. Med"},{"key":"10.1016\/j.ejphar.2025.177520_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2019.03.005","article-title":"Gene-environment interactions in Alzheimer's disease: a potential path to precision medicine","volume":"199","author":"Eid","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177520_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105046","article-title":"Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease","volume":"147","author":"El Gaamouch","year":"2021","journal-title":"Neurochem. Int."},{"issue":"14","key":"10.1016\/j.ejphar.2025.177520_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/nu15143204","article-title":"Dietary patterns and Alzheimer's disease: an updated review linking nutrition to neuroscience","volume":"15","author":"Ellouze","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073330","article-title":"Alzheimer's disease pathogenesis: role of autophagy and mitophagy focusing in microglia","volume":"22","author":"Eshraghi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002854.pub4","article-title":"Vitamin E for Alzheimer's dementia and mild cognitive impairment","volume":"4","author":"Farina","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2025.177520_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/472932","article-title":"Antioxidant therapies for Alzheimer's disease","volume":"2012","author":"Feng","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib51","article-title":"Antioxidant therapies for Alzheimer's disease","volume":"2012","author":"Feng","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13020191","article-title":"CoQ(10) and mitochondrial dysfunction in Alzheimer's disease","volume":"13","author":"Fi\u0161ar","year":"2024","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/antiox13020191","article-title":"CoQ10 and mitochondrial dysfunction in alzheimer's disease","volume":"13","author":"Fi\u0161ar","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177520_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00037","article-title":"Challenges for Alzheimer's disease therapy: insights from novel mechanisms beyond memory defects","volume":"12","author":"Frozza","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177520_bib55","article-title":"Natural acetylcholinesterase inhibitors: a multi-targeted therapeutic potential in Alzheimer's disease","volume":"11","author":"Gajendra","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.ejphar.2025.177520_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2025.127612","article-title":"Assessment of neuroprotective potential of Cuscuta reflexa in aluminium chloride-induced experimental model of Alzheimer's disease: in vitro and in vivo studies","volume":"88","author":"Gangarde","year":"2025","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3892\/etm.2023.12143","article-title":"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease","volume":"26","author":"Gao","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2025.177520_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.654931","article-title":"The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain","volume":"13","author":"Gasiorowska","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177520_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fphar.2018.00440","article-title":"Targeting renin-angiotensin system against Alzheimer's disease","volume":"9","author":"Gebre","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib60","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/jnc.15471","article-title":"Basal forebrain cholinergic system in the dementias: vulnerability, resilience, and resistance","volume":"158","author":"Geula","year":"2021","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib61","first-page":"153","article-title":"Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial","volume":"10","author":"Gharagozli","year":"2017","journal-title":"J. Med. Life"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.14283\/jpad.2021.6","article-title":"Nutrition-based approaches in clinical trials targeting cognitive function: highlights of the CTAD 2020","volume":"8","author":"Giudici","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13311-022-01201-2","article-title":"Disease-modifying therapies for Alzheimer's disease: more questions than answers","volume":"19","author":"Golde","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177520_bib64","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.pnpbp.2009.07.033","article-title":"Plants with neurobiological activity as potential targets for drug discovery","volume":"33","author":"Gomes","year":"2009","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70069","article-title":"Alterations in neuronal nicotinic acetylcholine receptors in the pathogenesis of various cognitive impairments","volume":"30","author":"Guan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177520_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122504","article-title":"Role of vitamin E in the treatment of Alzheimer's disease: evidence from animal models","volume":"18","author":"Gugliandolo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177520_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102192","article-title":"Passive immunotherapy for Alzheimer's disease","volume":"94","author":"Guo","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2025.177520_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jnc.14052","article-title":"Cholinergic modulation of the hippocampal region and memory function","volume":"142","author":"Haam","year":"2017","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177520_bib69","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","article-title":"The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability","volume":"185","author":"Hallacli","year":"2022","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib70","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib71","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177520_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7321-7_1","article-title":"NMDA receptors in the central nervous system","volume":"1677","author":"Hansen","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.177520_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-7075-2-22","article-title":"Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug","volume":"2","author":"Hardeland","year":"2005","journal-title":"Nutr. Metab."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-2009-1068","article-title":"Challenges associated with metal chelation therapy in Alzheimer's disease","volume":"17","author":"Hegde","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2012.08.005","article-title":"Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis","volume":"46","author":"Holzer","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2025.177520_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/175062","article-title":"Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease","volume":"2014","author":"Hroudov\u00e1","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5498\/wjp.v1.i1.8","article-title":"Cerebrospinal fluid and blood biomarkers in Alzheimer's disease","volume":"1","author":"Humpel","year":"2011","journal-title":"World J. Psychiatr."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7150\/ijbs.23247","article-title":"Role of plant derived alkaloids and their mechanism in neurodegenerative disorders","volume":"14","author":"Hussain","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7150\/ijbs.23247","article-title":"Role of plant derived alkaloids and their mechanism in neurodegenerative disorders","volume":"14","author":"Hussain","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib80","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/EC-17-0111","article-title":"Endocrinology and the brain: corticotropin-releasing hormone signaling","volume":"6","author":"Inda","year":"2017","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.ejphar.2025.177520_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer's disease","volume":"107","author":"Ionescu-Tucker","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib82","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-021-01546-6","article-title":"Current status of clinical trials on tau immunotherapies","volume":"81","author":"Ji","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/npp.2011.199","article-title":"Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia","volume":"37","author":"Jones","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177520_bib84","article-title":"Therapeutic potential of polyphenols in the management of diabetic neuropathy","volume":"2021","author":"Kabir","year":"2021","journal-title":"Evid. base Compl. Alternative Med."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib85","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11064-007-9490-y","article-title":"Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine","volume":"33","author":"Kamal","year":"2008","journal-title":"Neurochem. Res."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11910-021-01140-z","article-title":"Molecular imaging of the cholinergic system in alzheimer and Lewy body dementias: expanding views","volume":"21","author":"Kanel","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib87","article-title":"Renin-angiotensin system: Updated understanding and role in physiological and pathophysiological states","volume":"15","author":"Kanugula","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2025.177520_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109737","article-title":"Memantine: Updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Karimi Tari","year":"2024","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/ijoy.ijoy_218_23","article-title":"Reducing stress with yoga: a systematic review based on multimodal biosignals","volume":"16","author":"Khajuria","year":"2023","journal-title":"Int. J. Yoga"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-201433","article-title":"Spiritual fitness: a new dimension in Alzheimer's disease prevention","volume":"80","author":"Khalsa","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Transl. Neurodegener."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib92","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ajcn\/nqab018","article-title":"Exercise, diet, and cognition in a 4-year randomized controlled trial: dose-Responses to Exercise Training (DR's EXTRA)","volume":"113","author":"Komulainen","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib93","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1582-4934.2008.00557.x","article-title":"Chaperone signalling complexes in Alzheimer's disease","volume":"13","author":"Koren","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib94","first-page":"405","article-title":"[The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease]","volume":"38","author":"Kowalska","year":"2004","journal-title":"Neurol. Neurochir. Pol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib95","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3390\/ijms21072568","article-title":"Role of somatostatin in the regulation of central and peripheral factors of satiety and obesity","volume":"21","author":"Kumar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177520_bib96","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model","volume":"33","author":"Kumar","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoisel\u00e9e","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejphar.2025.177520_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.07.039","article-title":"Interactions between \u03b1-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis","volume":"66","author":"Lebold","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177520_bib99","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fnins.2019.00869","article-title":"Roles of neuropeptide Y in neurodegenerative and Neuroimmune diseases","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177520_bib100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-3-8","article-title":"Tau exon 10 alternative splicing and tauopathies","volume":"3","author":"Liu","year":"2008","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib101","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2025.177520_bib102","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fnins.2018.00632","article-title":"Iron and Alzheimer's disease: from pathogenesis to therapeutic implications","volume":"12","author":"Liu","year":"2018","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020537","article-title":"Potential of caffeine in Alzheimer's disease-A review of experimental studies","volume":"13","author":"Londzin","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib104","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","article-title":"Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice","volume":"157","author":"Lu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177520_bib105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-5-24","article-title":"Heat shock protein 90 in neurodegenerative diseases","volume":"5","author":"Luo","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2025.177520_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.ejphar.2025.177520_bib107","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/brainsci13121610","article-title":"Exploring the role of neuroplasticity in development, aging, and neurodegeneration","volume":"13","author":"Marzola","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2025.177520_bib108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.01.024","article-title":"Galantamine inhibits \u03b2-amyloid aggregation and cytotoxicity","volume":"280","author":"Matharu","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib109","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/aje\/kwz047","article-title":"Invited commentary: examining sex\/gender differences in risk of Alzheimer disease and related dementias-challenges and future directions","volume":"188","author":"Mayeda","year":"2019","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in Alzheimer's disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib111","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajpath.2013.10.010","article-title":"\u03b17 nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles","volume":"184","author":"Medeiros","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib112","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1002\/alz.13015","article-title":"Impact of Alzheimer's association support and engagement in the AD\/ADRD research community through the COVID-19 pandemic and beyond","volume":"19","author":"Meyers","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib113","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer's disease: a clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib114","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/ADR-210061","article-title":"Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer's disease and future perspectives","volume":"6","author":"Moreira","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.ejphar.2025.177520_bib115","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf026","article-title":"New horizons in menopause, menopausal hormone therapy, and Alzheimer's disease: current insights and future directions","author":"Mosconi","year":"2025","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib116","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/13872877241289602","article-title":"The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: anti-neurodegenerative benefits of acetylcholinesterase inhibitors","volume":"102","author":"Moss","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"16","key":"10.1016\/j.ejphar.2025.177520_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162041","article-title":"The role of c-Abl tyrosine kinase in brain and its pathologies","volume":"12","author":"Motaln","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101729","article-title":"Exploring the role of COX-2 in Alzheimer's disease: potential therapeutic implications of COX-2 inhibitors","volume":"31","author":"Moussa","year":"2023","journal-title":"Saudi Pharm. J."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051054","article-title":"Dietary polyphenols as a protection against cognitive decline: evidence from animal experiments; mechanisms and limitations","volume":"12","author":"Naomi","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib120","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging. Dis"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib121","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/cr500638n","article-title":"Amyloid \u03b2 protein and Alzheimer's disease: when computer simulations complement experimental studies","volume":"115","author":"Nasica-Labouze","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2025.177520_bib122","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fphar.2018.00557","article-title":"Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders","volume":"9","author":"Neag","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177520_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111623","article-title":"Advances in developing therapeutic strategies for Alzheimer's disease","volume":"139","author":"Nguyen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib124","doi-asserted-by":"crossref","first-page":"754","DOI":"10.5498\/wjp.v11.i10.754","article-title":"Therapeutic role of yoga in neuropsychological disorders","volume":"11","author":"Nourollahimoghadam","year":"2021","journal-title":"World J. Psychiatr."},{"issue":"17","key":"10.1016\/j.ejphar.2025.177520_bib125","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Nowicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib126","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/ijms10031226","article-title":"Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element","volume":"10","author":"Olivares","year":"2009","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib127","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40035-023-00361-1","article-title":"An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers","volume":"12","author":"Olson","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","article-title":"Rivastigmine in the treatment of Alzheimer's disease: an update","volume":"2","author":"Onor","year":"2007","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejphar.2025.177520_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.676239","article-title":"Monoamine oxidase inhibitors: a review of their anti-inflammatory therapeutic potential and mechanisms of action","volume":"12","author":"Ostadkarampour","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib131","first-page":"Br357","article-title":"Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease","volume":"11","author":"Pak","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2025.177520_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101560","article-title":"A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: potential pharmacotherapeutic priorities","volume":"75","author":"Panda","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"22","key":"10.1016\/j.ejphar.2025.177520_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer's disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib134","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000255105","article-title":"Vitamin E use is associated with improved survival in an Alzheimer's disease cohort","volume":"28","author":"Pavlik","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.177520_bib136","article-title":"Tangled connection of gut microbiome and Alzheimer's disease","volume":"vol. 26","author":"Pujari","year":"2025"},{"key":"10.1016\/j.ejphar.2025.177520_bib137","series-title":"Microbiota-Gut-Brain Axis and CNS Disorders","first-page":"19","article-title":"Chapter 2 - role of microbiota-gut-brain axis in Alzheimer's disease and possible interventions","author":"Pujari","year":"2025"},{"key":"10.1016\/j.ejphar.2025.177520_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1011740","article-title":"Natural product-based pharmacological studies for neurological disorders","volume":"13","author":"Puri","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib139","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.ejphar.2025.177520_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121885","article-title":"Innate immune cell death in neuroinflammation and Alzheimer's disease","volume":"11","author":"Rajesh","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib141","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"19","key":"10.1016\/j.ejphar.2025.177520_bib142","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.0000000000207757","article-title":"Antiamyloid monoclonal antibody therapy for Alzheimer disease","volume":"101","author":"Ramanan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2025.177520_bib143","series-title":"Naturally Occurring Chemicals against Alzheimer's Disease","first-page":"83","article-title":"Chapter 3.1.4 - galantamine","author":"Rathi","year":"2021"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib144","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","article-title":"Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management","volume":"16","author":"Rawat","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"21","key":"10.1016\/j.ejphar.2025.177520_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer's disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib146","first-page":"775","article-title":"Rivastigmine for the treatment of dementia associated with Parkinson's disease","volume":"3","author":"Reingold","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib147","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s12272-013-0205-4","article-title":"Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress","volume":"40","author":"Rinwa","year":"2017","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib148","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib149","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/1570159X14666160325115909","article-title":"Environmental enrichment as a positive behavioral intervention across the lifespan","volume":"15","author":"Sampedro-Piquero","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177520_bib150","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/pharmrev.124.001117","article-title":"Somatostatin: Linking cognition and Alzheimer disease to therapeutic targeting","volume":"76","author":"Sandoval","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010360","article-title":"Alpha-synuclein contribution to neuronal and glial damage in Parkinson's disease","volume":"25","author":"Saramowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2025.177520_bib152","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","article-title":"Neurotrophic factors in Alzheimer's disease: role of axonal transport","volume":"7","author":"Schindowski","year":"2008","journal-title":"Gene Brain Behav."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib153","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12031-011-9588-1","article-title":"c-Abl in neurodegenerative disease","volume":"45","author":"Schlatterer","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177520_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119129","article-title":"A review on advances of treatment modalities for Alzheimer's disease","volume":"276","author":"Se Thoe","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib155","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer's therapeutics","volume":"20","author":"Sharma","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177520_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib157","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177520_bib158","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2025.177520_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177520_bib160","series-title":"Encyclopedia of Biomedical Gerontology","first-page":"149","article-title":"Aging of the brain","author":"Srivas","year":"2020"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib161","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/pr.54.3.469","article-title":"Amyloid precursor protein, presenilins, and \u03b1-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease","volume":"54","author":"Suh","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib162","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a natural antioxidant: an overview of the current evidence and perspectives","volume":"4","author":"Surai","year":"2015","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177520_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1303111","article-title":"Alzheimer's disease: the role of extrinsic factors in its development, an investigation of the environmental enigma","volume":"14","author":"Suresh","year":"2023","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10091479","article-title":"Oxidative stress and beta amyloid in Alzheimer's disease. Which comes first: the chicken or the egg?","volume":"10","author":"Tamagno","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177520_bib166","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ibra.12098","article-title":"Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications","volume":"9","author":"Tang","year":"2023","journal-title":"Ibrain"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib167","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13430","article-title":"BACE1: more than just a \u03b2-secretase","volume":"23","author":"Taylor","year":"2022","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib168","first-page":"409","article-title":"Negative neuroplasticity in chronic traumatic brain injury and implications for neurorehabilitation","volume":"24","author":"Tomaszczyk","year":"2014","journal-title":"Neuropsychol. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib169","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.freeradbiomed.2011.05.017","article-title":"Vitamins C and E: beneficial effects from a mechanistic perspective","volume":"51","author":"Traber","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177520_bib170","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3390\/ijms22042110","article-title":"Imaging techniques in Alzheimer's disease: a review of applications in early diagnosis and longitudinal monitoring","volume":"22","author":"van Oostveen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177520_bib171","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3928\/02793695-20100302-01","article-title":"How neuroplasticity and cognitive reserve protect cognitive functioning","volume":"48","author":"Vance","year":"2010","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"10.1016\/j.ejphar.2025.177520_bib172","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of aducanumab in the treatment of Alzheimer's disease: challenges and opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib173","article-title":"An insider's perspective on FDA approval of aducanumab","volume":"9","author":"Wang","year":"2023","journal-title":"Alzheimers Dement (N Y)"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177520_bib174","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177520_bib175","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib176","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib177","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-210735","article-title":"Flavonoids with potential anti-amyloidogenic effects as therapeutic drugs for treating Alzheimer's disease","volume":"84","author":"Wang","year":"2021","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejphar.2025.177520_bib178","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"issue":"7","key":"10.1016\/j.ejphar.2025.177520_bib179","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00002512-200421070-00004","article-title":"Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy","volume":"21","author":"Wilkinson","year":"2004","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.ejphar.2025.177520_bib180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bbadis.2014.12.005","article-title":"Curcumin boosts DHA in the brain: implications for the prevention of anxiety disorders","volume":"1852","author":"Wu","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.ejphar.2025.177520_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29122812","article-title":"Role of tau protein in neurodegenerative diseases and development of its targeted drugs: a literature review","volume":"29","author":"Yang","year":"2024","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177520_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020343","article-title":"Potentials of neuropeptides as therapeutic agents for neurological diseases","volume":"10","author":"Yeo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.177520_bib183","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.ejphar.2025.177520_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114543","article-title":"Stem cells in central nervous system diseases: promising therapeutic strategies","volume":"369","author":"Ying","year":"2023","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177520_bib185","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer's disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib186","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WNF.0000000000000427","article-title":"Effects of rivastigmine on brain functional networks in patients with Alzheimer disease based on the graph theory","volume":"44","author":"Zhang","year":"2021","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib187","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib188","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib189","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-6-27","article-title":"Biology and pathophysiology of the amyloid precursor protein","volume":"6","author":"Zheng","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib190","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5568011","article-title":"The neuroprotective effects of moderate and regular caffeine consumption in Alzheimer's disease","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177520_bib191","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177520_bib192","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17061","article-title":"Gut microbiota and its metabolites in Alzheimer's disease: from pathogenesis to treatment","volume":"12","author":"Zou","year":"2024","journal-title":"PeerJ"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T08:48:35Z","timestamp":1746953315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":191,"alternative-id":["S0014299925002742"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177520","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring Alzheimer's disease treatment: Established therapies and novel strategies for future care","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177520"}}